Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    Forecasted

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds further development and validation of new molecular and cellular analysis technologies to improve basic and clinical cancer research, excluding projects using existing technologies for new targets.

    HHS-NIH11Due Nov 10, 2026· 17d$300,000

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development for improving analysis and handling of biospecimens in basic or clinical cancer research, focusing on proof-of-concept studies.

    HHS-NIH11Due Nov 10, 2026· 17d$150,000

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.

    HHS-NIH11Forecasted Jun 4, 2027$150,000Forecasted

    Forecast to Publish a Funding Opportunity Announcement for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

    The National Cancer Institute will soon invite applications to develop innovative, user-friendly informatics technologies that advance cancer research, spanning early tool development to initial dissemination.

    HHS-NIH11Due Oct 19, 2027$300,000

    Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

    This upcoming NIH grant will fund innovative research developing advanced bioinformatics and computational biology tools to improve biomedical data analysis and health outcomes, encouraging interdisciplinary and technology-driven projects.

    HHS-NIH11Due Mar 5, 2029$250,000